SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverRGEN
HealthcareNMSUSD

Repligen Corporation

$001234567890012345678900123456789.0012345678900123456789+12.8%
52w low (est.) $116.91$189.10 52w high (est.)
Market data
Market cap
USD8.17B
52-week range
USD100.99 – USD175.77
Beta (vs market)
1.06
Sector
Healthcare
Data quality
96/100
Valuation
P/E ratio
159.2x
DCF fair value
USD57.95
Margin of safety
-61.0%
Forward P/E
56.9x
PEG ratio
2.28
Quality & efficiency
Moat score
55/100
Return on equity
2.5%
Profit margin
6.7%
Debt / equity
0.33
Growth & analysts
Revenue growth (YoY)
+14.8%
Analyst target
USD177.05
Target upside
+19.2%
Analysts covering
20

About Repligen Corporation

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Valuation

ValueGrowthProfitHealthIncome32QUALITY
Overall Rating
33
Reduce
Reduce

Derived from filed metrics · High confidence (96% of the inputs available)

Moat Score55
DCF Intrinsic Value
USD57.95-61.0% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD8.17B
P/E Ratio
159.2
Dividend Yield
0.00%
Revenue Growth
+14.8%
Profit Margin
6.7%
ROE
2.5%
Debt / Equity
0.33
Beta
1.06
vs Healthcare sector:P/E 159 vs 28 Moat 55 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · RGEN